{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:39:00Z","timestamp":1770748740123,"version":"3.50.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>The incidence of prematurity-related complications has decreased due to advancements in medical preventive and supportive measures, but the rate of neurodevelopmental impairment secondary to prematurity continues to increase. Due to the high metabolic demand of the central nervous system during early development and the age-related sensitivity of the cerebral white matter, perinatal intermittent hypoxia can lead to significant cerebral pathology persisting into adulthood. Caffeine citrate is one of the mainstay medical treatments for apnea of prematurity and is widely used in many neonatal intensive care units. Caffeine citrate's benefits include reducing time on mechanical ventilation, enhancing extubation success, and decreasing the incidence of bronchopulmonary dysplasia. There is also mounting evidence that caffeine citrate benefits neurodevelopmental outcomes, attributable to its positive effect on respiratory status and other mechanisms. Research has shown that caffeine citrate exerts an anti-inflammatory effect via the antagonism of adenosine receptors, reduces the production of reactive oxygen species, and supports the plasticity of the central nervous system. This article aims to review the most up-to-date evidence on caffeine citrate's effects on neuroprotection and its role in reducing the severity of neurodevelopmental impairment associated with prematurity.<\/jats:p>","DOI":"10.3389\/fped.2025.1682903","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:44:20Z","timestamp":1766040260000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The utility of caffeine citrate as a neuroprotectant in the early life of premature newborns: a literature review of the effects on neurodevelopmental outcomes"],"prefix":"10.3389","volume":"13","author":[{"given":"Lauren","family":"Phung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaithlyn","family":"Duong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawad","family":"Obeid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"B1","volume-title":"Infant Apnea","author":"Kondamudi","year":"2023"},{"key":"B2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5409\/wjcp.v4.i4.81","article-title":"Caffeine therapy in preterm infants","volume":"4","author":"Abdel-Hady","year":"2015","journal-title":"World J Clin Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/children6110118","article-title":"Caffeine and clinical outcomes in premature neonates","volume":"6","author":"Kumar","year":"2019","journal-title":"Children"},{"key":"B4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/cns.12684","article-title":"The neuroprotective effects of caffeine in neurodegenerative diseases","volume":"23","author":"Kolahdouzan","year":"2017","journal-title":"CNS Neurosci Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1042\/BJ20080489","article-title":"Caffeine induces Ca2+ release by reducing the threshold for luminal Ca2+ activation of the ryanodine receptor","volume":"414","author":"Kong","year":"2008","journal-title":"Biochem J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0170545","DOI":"10.1371\/journal.pone.0170545","article-title":"Single dose caffeine protects the neonatal mouse brain against hypoxia ischemia","volume":"12","author":"Winerdal","year":"2017","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3390\/LIFE12101514","article-title":"Therapeutic interventions in rat models of preterm hypoxic ischemic injury: effects of hypothermia, caffeine, and the influence of sex","volume":"12","author":"McLeod","year":"2022","journal-title":"Life (Basel)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/J.IJDEVNEU.2018.02.001","article-title":"Behavioral and neuroanatomical outcomes in a rat model of preterm hypoxic-ischemic brain injury: effects of caffeine and hypothermia","volume":"70","author":"Potter","year":"2018","journal-title":"Int J Dev Neurosci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/BIOMEDICINES11010185","article-title":"Sex differences in microglia activation in a rodent model of preterm hypoxic ischemic injury with caffeine treatment","volume":"11","author":"McLeod","year":"2023","journal-title":"Biomedicines"},{"key":"B10","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/ana.21008","article-title":"Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury","volume":"60","author":"Back","year":"2006","journal-title":"Ann Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"908045","DOI":"10.3389\/fcell.2022.908045","article-title":"Caffeine restores neuronal damage and inflammatory response in a model of intraventricular hemorrhage of the preterm newborn","volume":"10","author":"Alves-Martinez","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/S41372-024-01939-X","article-title":"Caffeine for apnea and prevention of neurodevelopmental impairment in preterm infants: systematic review and meta-analysis","volume":"44","author":"Oliphant","year":"2024","journal-title":"J Perinatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/JAMA.2011.2024","article-title":"Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity","volume":"307","author":"Schmidt","year":"2012","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/ana.22098","article-title":"Caffeine and brain development in very preterm infants","volume":"68","author":"Doyle","year":"2010","journal-title":"Ann Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/jamapediatrics.2017.0238","article-title":"Academic performance, motor function, and behavior 11 years after neonatal caffeine citrate therapy for apnea of prematurity: an 11-year follow-up of the CAP randomized clinical trial","volume":"171","author":"Schmidt","year":"2017","journal-title":"JAMA Pediatr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"103495","DOI":"10.1016\/j.resp.2020.103495","article-title":"Early application of caffeine improves white matter development in very preterm infants","volume":"281","author":"Liu","year":"2020","journal-title":"Respir Physiol Neurobiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/pr.2015.72","article-title":"A pilot randomized trial of high-dose caffeine therapy in preterm infants","volume":"78","author":"McPherson","year":"2015","journal-title":"Pediatr Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/S41372-022-01333-5","article-title":"Five-year outcomes of premature infants randomized to high or standard loading dose caffeine","volume":"42","author":"McPherson","year":"2022","journal-title":"J Perinatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1111\/jpc.14446","article-title":"Early high-dose caffeine citrate for extremely preterm infants: neonatal and neurodevelopmental outcomes","volume":"55","author":"Firman","year":"2019","journal-title":"J Paediatr Child Health"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/S41390-025-04387-1","article-title":"Cumulative caffeine exposure predicts neurodevelopmental outcomes in premature infants","author":"Ostrem","year":"2025","journal-title":"Pediatr Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1007\/s12035-020-01867-9","article-title":"Defining a time window for neuroprotection and Glia modulation by caffeine after neonatal hypoxia-ischaemia","volume":"57","author":"Di Martino","year":"2020","journal-title":"Mol Neurobiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.34763\/devperiodmed.20172104.328335","article-title":"Intraventricular hemorrhage in premature infants with respiratory distress syndrome treated with surfactant: incidence and risk factors in the prospective cohort study","volume":"21","author":"Helwich","year":"2017","journal-title":"Dev Period Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1158286","article-title":"A two-center retrospective study: association of early caffeine administration and oxygen radical diseases in neonatology in Chinese preterm neonates","volume":"11","author":"Ye","year":"2023","journal-title":"Front Pediatr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0189152","DOI":"10.1371\/journal.pone.0189152","article-title":"Shifting the boundaries for early caffeine initiation in neonatal practice: results of a prospective, multicenter study on very preterm infants with respiratory distress syndrome","volume":"12","author":"Borszewska-Kornacka","year":"2017","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000534497","article-title":"Early versus late caffeine therapy administration in preterm neonates: an updated systematic review and meta-analysis","volume":"121","author":"Karlinski Vizentin","year":"2024","journal-title":"Neonatology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1055\/S-0041-1727157","article-title":"Effects of different onset times of early caffeine treatment on mesenteric tissue oxygenation and necrotizing enterocolitis: a prospective, randomized study","volume":"40","author":"Ozkan","year":"2023","journal-title":"Am J Perinatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8701598","article-title":"Is early preventive caffeine safe and effective in premature neonates? A clinical trial","volume":"2022","author":"Sajjadian","year":"2022","journal-title":"Int J Pediatr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3346\/jkms.2015.30.12.1828","article-title":"Early caffeine use in very low birth weight infants and neonatal outcomes: a systematic review and meta-analysis","volume":"30","author":"Park","year":"2015","journal-title":"J Korean Med Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e20181348","DOI":"10.1542\/PEDS.2018-1348","article-title":"Early caffeine administration and neurodevelopmental outcomes in preterm infants","volume":"143","author":"Lodha","year":"2019","journal-title":"Pediatrics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3109\/14767058.2015.1041493","article-title":"Effect of early caffeine on neurodevelopmental outcome of very low-birth weight newborns","volume":"29","author":"Gupte","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000540540","article-title":"Protective effects of early neonatal methylxanthine treatment on cognitive and language outcomes in premature infants with and without high-risk perinatal factors","volume":"47","author":"McLeod","year":"2025","journal-title":"Dev Neurosci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa073679","article-title":"Long-Term effects of caffeine therapy for apnea of prematurity","volume":"357","author":"Schmidt","year":"2007","journal-title":"N Engl J Med"},{"key":"B33","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-4047","article-title":"Neurobehavioral outcomes 11 years after neonatal caffeine therapy for apnea of prematurity","volume":"141","author":"M\u00fcrner-Lavanchy","year":"2018","journal-title":"Pediatrics"},{"key":"B34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpeds.2020.11.058","article-title":"Perinatal risk and protective factors in the development of diffuse white matter abnormality on term-equivalent age magnetic resonance imaging in infants born very preterm","volume":"233","author":"Parikh","year":"2021","journal-title":"J Pediatr"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1682903\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:44:22Z","timestamp":1766040262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1682903\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":34,"alternative-id":["10.3389\/fped.2025.1682903"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1682903","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"article-number":"1682903"}}